CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 389 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 51-75 of 102 matching filings.

Per page
25
Current page
3
8-K File 001-39126

CURRENT REPORT

Filing date
15 Aug 2023
Reporting date
11 Aug 2023
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
14 Dec 2022
Reporting date
13 Dec 2022
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
28 Nov 2022
Reporting date
28 Nov 2022
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
24 Oct 2022
Reporting date
21 Oct 2022
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
19 Aug 2022
Reporting date
18 Aug 2022
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
19 Jul 2021
Reporting date
19 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
01 Jul 2021
Reporting date
28 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
18 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .